Page 94 - Read Online

Page 8 of 9 Othman et al. J Cancer Metastasis Treat 2018;4:50 I http://dx.doi.org/10.20517/2394-4722.2018.41

Consent for publication
Not applicable.

Copyright
© The Author(s) 2018.

REFERENCES
1. Sekimizu M, Sunami S, Nakazawa A, Hayashi Y, Okimoto Y, Saito AM, Horibe K, Tsurusawa M, Mori T. Chromosome abnormalities in
advanced stage T-cell lymphoblastic lymphoma of children and adolescents: a report from Japanese Paediatric Leukaemia/Lymphoma Study
Group (JPLSG) and review of the literature. Br J Haematol 2011;154:612-7.
2. Baleydier F, Decouvelaere AV, Bergeron J, Gaulard P, Canioni D, Bertrand Y, Lepretre S, Petit B, Dombret H, Beldjord K, Molina T, Asnafi V,
Macintyre E. T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect
clinical outcome. Clin Cancer Res 2008;14:692-700.
3. Lones MA, Heerema NA, Le Beau MM, Sposto R, Perkins SL, Kadin ME, Kjeldsberg CR, Meadows A, Siegel S, Buckley J, Abromowitch
M, Kersey J, Bergeron S, Cairo MS, Sanger WG. Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and
adolescents: a report from CCG-E08. Cancer Genet Cytogenet 2007;172:1-11.
4. Ellison DA, Parham DM, Sawyer JR. Cytogenetic findings in pediatric T-lymphoblastic lymphomas: one institution’s experience and a re-
view of the literature. Pediatr Dev Pathol 2005;8:550-6.
5. Claussen U, Michel S, Mühlig P, Westermann M, Grummt UW, Kromeyer-Hauschild K, Liehr T. Demystifying chromosome preparation
and the implications for the concept of chromosome condensation during mitosis. Cytogenet Genome Res 2002;98:136-46.
6. Othman MA, Grygalewicz B, Pienkowska-Grela B, Rygier J, Ejduk A, Rincic M, Melo JB, Carreira IM, Meyer B, Liehr T. A novel IGH@
gene rearrangement associated with CDKN2A/B deletion in young adult B-cell acute lymphoblastic leukemia. Oncol Lett 2016;11:2117-22.
7. Weise A, Mrasek K, Fickelscher I, Claussen U, Cheung SW, Cai WW, Liehr T, Kosyakova N. Molecular definition of high-resolution multi-
color banding probes: first within the human DNA sequence anchored FISH banding probe set. J Histochem Cytochem 2008;56:487-93.
8. Liehr T, Claussen U. Current developments in human molecular cytogenetic techniques. Curr Mol Med 2002;2:283-97.
9. Kang ZJ, Liu YF, Xu LZ, Long ZJ, Huang D, Yang Y, Liu B, Feng JX, Pan YJ, Yan JS, Liu Q. The Philadelphia chromosome in leukemo-
genesis. Chin J Cancer 2016;35:48.
10. Zhou MH, Yang QM. NUP214 fusion genes in acute leukemia (Review). Oncol Lett 2014;8:959-62.
11. Hagemeijer A, Graux C. ABL1 rearrangements in T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer 2010;49:299-308.
12. Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R, Vermeesch JR, Stul M, Dutta B, Boeckx N, Bosly A, Heimann P, Uyt-
tebroeck A, Mentens N, Somers R, MacLeod RA, Drexler HG, Look AT, Gilliland DG, Michaux L, Vandenberghe P, Wlodarska I, Marynen
P, Hagemeijer A. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 2004;36:1084-9.
13. Chiaretti S, Tavolaro S, Ghia EM, Ariola C, Matteucci C, Elia L, Maggio R, Messina M, Ricciardi MR, Vitale A, Ritz J, Mecucci C, Guarini A,
Foà R. Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis. Haematologica
2007;92:619-26.
14. Graux C, Stevens-Kroef M, Lafage M, Dastugue N, Harrison CJ, Mugneret F, Bahloula K, Struski S, Grégoire MJ, Nadal N, Lippert E, Ta-
viaux S, Simons A, Kuiper RP, Moorman AV, Barber K, Bosly A, Michaux L, Vandenberghe P, Lahortiga I, De Keersmaecker K, Wlodarska
I, Cools J, Hagemeijer A, Poirel HA; Groupe Francophone de Cytogénétique Hématologique; Belgian Cytogenetic Group for Hematology
and Oncology. Heterogeneous patterns of amplification of the NUP214-ABL1 fusiongene in T-cell acute lymphoblastic leukemia. Leukemia
2009;23:125-33.
15. Basso K, Mussolin L, Lettieri A, Brahmachary M, Lim WK, Califano A, Basso G, Biondi A, Cazzaniga G, Rosolen A. T-cell lymphoblastic
lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses. Genes
Chromosomes Cancer 2011;50:1063-75.
16. Clarke S, O’Reilly J, Romeo G, Cooney J. NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable
response to imatinib therapy post relapse. Leuk Res 2011;35:e131-3.
17. Duployez N, Grzych G, Ducourneau B, Alarcon Fuentes M, Grardel N, Boyer T, Abou Chahla W, Bruno B, Nelken B, Clappier E, Preud-
homme C. NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine
kinase inhibitors. Haematologica 2016;101:e133-4.
18. Maurer BJ, Lai E, Hamkalo BA, Hood L, Attardi G. Novel submicroscopic extrachromosomal elements containing amplified genes in hu-
man cells. Nature 1987;327:434-7.
19. Albertson DG. Gene amplification in cancer. Trends Genet 2006;22:447-55.
20. Turner KM, Deshpande V, Beyter D, Koga T, Rusert J, Lee C, Li B, Arden K, Ren B, Nathanson DA, Kornblum HI, Taylor MD, Kaushal S,
Cavenee WK, Wechsler-Reya R, Furnari FB, Vandenberg SR, Rao PN, Wahl GM, Bafna V, Mischel PS. Extrachromosomal oncogene am-
plification drives tumour evolution and genetic heterogeneity. Nature 2017;543:122-5.
21. Kim HJ, Woo HY, Koo HH, Tak EY, Kim SH. ABL oncogene amplification with p16(INK4a) gene deletion in precursor T-cell acute lym-
phoblastic leukemia/lymphoma: report of the first case. Am J Hematol 2004;76:360-3.
22. Stergianou K, Fox C, Russell NH. Fusion of NUP214 to ABL1 on amplified episomes in T-ALL--implications for treatment. Leukemia
2005;19:1680-1.
23. Kawamata N, Zhang L, Ogawa S, Nannya Y, Dashti A, Lu D, Lim S, Schreck R, Koeffler HP. Double minute chromosomes containing
MYB gene and NUP214-ABL1 fusion gene in T-cell leukemia detected by single nucleotide polymorphism DNA microarray and fluores-
cence in situ hybridization. Leuk Res 2009;33:569-71.
24. De Keersmaecker K, Porcu M, Cox L, Girardi T, Vandepoel R, de Beeck JO, Gielen O, Mentens N, Bennett KL, Hantschel O. NUP214-